SID 2026Late-breaking abstract LB1144
The use of JAK inhibitors for immune-related adverse events: an institutional experience
Osman A, Mittal L
SID Annual Meeting 2026Late-breaking abstractsChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: JAK inhibitors & other targeted pills
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1175 · Not in PubMed: details from Crossref